Synthesis and biological activity of a pyridinicisostere of MDL 72832 and its enantiomers as serotoninergic 5-HT1A ligands

Medicinal Chemistry Research

Volumn 6, Issue 6, 1996, Pages 392-399

  Comoy, Corinne ^a   Benarab, Abdelhakim ^a   Monteil, André ^b   Leinot, Michel ^b   Massingham, Roy ^b   Guillaumet, Gérald ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b CERM Centre Europeen de Recherches Mauvernay   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001061904     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Arvidsson, L. E.; Hacksell, U.; Nilsson, J. L. G.; Hjorth, S.; Carlsson, A.; Lindberg, P.; Sanchez, D.; Wikström, H. J. Med. Chem. 1981, 24, 921.
2. Middlemiss, D. N.; Fozard, J. R. Eur. J. Pharm. 1983, 90, 151.
3. Traber, J.; Glaser, T. Trends Pharmacol. Sci. 1987, 8, 432.
4. Romero, A. G.; Mc Call, R. B. Ann. Rep. Med. Chem. 1992, 270, 21.
5. Fuller, R. W.; Robertson, D. M. Ann. Rep. Med. Chem. 1991, 26, 23.
6. a) Richardson, B. P.; Hoyer, D. Serotonin : From cell biology to pharmacology and therapeutics, pp 265-276; Paoletti, R., Ed.; Drodrecht : Kleewer, 1990.
7. b) Levy, A. D.; Van der Kar, L. D. Life Sci. 1992, 51, 83.
8. c) Taylor, D. P.; Moon, S. L; Neuropeptides 1991, 19, 15.
9. Kastenhoz, K. V.; Crismon, M. L. Clin. Pharm. 1984, 3, 600.
10. a) Hibert, M. H.; Gittos, M. W.; Middlemiss, D. N.; Mir, A. K.; Fozard, J. R. J. Med. Chem. 1988, 31, 1087.
11. b) Hibert, M.; Moser, P. Drugs of the Future 1990, 15, 159.
12. a) Moser, P. C.; Tricklebank, M. D.; Middlemiss, D. N.; Mir, A. K.; Hibert, M. H.; Fozard, J. R. Br. J. Pharmacol. 1990, 99, 343.
13. b) Mir, A. K.; Hibert, M. H.; Tricklebank, M. D.; Middlemiss, D. N.; Kidd, E. J.; Fozard, J. R. Eur. J. Pharm. 1988, 149, 107.
14. Griebel, G.; Misslin, R; Pawlowski, M.; Guardiola-Lemaître, B.; Guillaumet, G.; Bizot-Espiard, J. G. Neuroreport 1992, 3, 84.
15. Besson, T.; Podona, T.; Baudin, M. L.; Coudert, G.; Guillaumet, G. Bioorg. Med. Chem. Lett. 1993, 3, 1935.
16. Podona, T.; Guardiola-Lemaître, B.; Caignard, D. H.; Adam, G.; Pfeiffer, B.; Renard, P.; Guillaumet, G. J. Med. Chem. 1994, 37, 1779.
17. Comoy, C.; Guillaumet, G. Heterocyclic Commun. 1996, 2, 25.
18. Comoy, C.; Marot, C.; Podona, T.; Baudin, M. L.; Morin-Allory, L.; Guillaumet, G.; Pfeiffer, B.; Caignard, D. H.; Renard, P.; Rettori, M. C.; Adam, G.; Guardiola-Lemaître, B. J. Med. Chem., submitted for publication.
19. Benarab, A.; Poirot, P.; Guillaumet, G. Heterocycles 1993, 36, 1589.
20. Mc Clure, D. E.; Arison, B. H.; Baldwin, J. J. J. Am. Chem. Soc. 1979, 101, 3666.
21. The Mitsunobu reaction was known in literature to avoid the racemization. For an example, see : Nakano, J.; Mimura, M.; Hayashida, M.; Kimura, K.; Nakanishi, T. Heterocycles 1983, 20, 1975.
22. Benarab, A; Comoy, C; Guillaumet, G. Heterocycles 1994, 38, 1641.
23. a) Peroutka, S. J. Brain Research 1985, 344, 167-171.
24. b) Waeber, C.; Schoeffer, P.; Palacios, J. M.; Hoyer, D.; Naunyn-Schmiedeberg's Archives of Pharmacology 1988, 337, 595-601.
25. c) Leysen, J. E.; Wiemegers, C. J. E.; Van Nueten, J. M.; Ledurem, P. M. Mol. Pharmocol. 1982, 21, 301-314.
26. d) Pazos, A.; Hoyer, D.; Palacios, J. M. European J. Pharmacol. 1984, 106, 539-546.
27. e) Battaglin, G. J. Neurochem. 1983, 41, 538-542.
28. Berendsen, H. H. G.; Jenck, J.; Brockamp, C. L. E. Pharmacol. Biochem. Behav. 1989, 33, 821.
29. a) Ruigt, G. S.; Englen, S.; Gerrits, A.; Verbon, F. Neuropsychobiology 1993, 28, 138.
30. b) Anderson, T. W. Introduction to multivariate statistical analysis; John Wiley and Sons, Ed., 1958.
31. c) Konig, J. F. R.; Kuppel, R. A. The rat brain : A stereotaxic atlas of the forebrain and lower parts of the brain stem, The Williams and Wilkins Co., Ed., 1963.
32. d) Morris, L. R. Fast digital signal processing software package, pp 11-296; Digital Equipment User's society (DECUS) program library, 1976.